Cureab Company
Cureab is a Swiss biotech company established in 2012, specializing in inflammation and oncology research. They develop therapeutic antibodies from target identification to clinical testing, with two monoclonal antibodies currently in late-stage pre-clinical development. Cureab is open to forming partnerships with academic and industrial entities.
Headquarters:
Riehen, Basel-Stadt, Switzerland
Employee Number:
1-10
Estimated Revenue:
Less than $1M
Technology:
Internet of Things
Industry:
Healthcare & Life Sciences